Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women

By Mellins C. A.   Chu C.   Malee K.   Allison S.   Smith R.   Harris L.   Higgins A.   Zorrilla C.   Landesman S.   Serchuck L.   Larussa P.  

AIDS Care, Vol. 20, Iss. 8, 2008-09 ,pp. : 958-968

Routledge Ltd

Access to resources Recommend Favorite

Characteristics of pregnant HIV-1 infected women in Europe

By Thorne C.   Newell M.-L.   Dunn D.   Peckham C.  

AIDS Care, Vol. 8, Iss. 1, 1996-02 ,pp. : 33-42

Routledge Ltd

Access to resources Recommend Favorite

Suboptimal Etravirine Activity is Common During Failure of Nevirapine-Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1

By  

Current HIV Research, Vol. 8, Iss. 3, 2010-04 ,pp. : 194-198

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive factors of antiretroviral treatment <4 weeks among HIV-infected pregnant women in Cayenne, French Guiana

By Elenga Narcisse   Hanf Matthieu   Nacher Mathieu  

AIDS Care, Vol. 24, Iss. 1, 2012-01 ,pp. : 46-53

Routledge Ltd

Access to resources Recommend Favorite

Transplacental Transfer of Antiretroviral Drugs and Newborn Birth Weight in HIV-Infected Pregnant Women

By  

Current HIV Research, Vol. 7, Iss. 6, 2009-01 ,pp. : 620-625

Bentham Science Publishers

Access to resources Recommend Favorite